Cullinan Oncology LLC
Price & Volume
Stats
See more52W Range | $5.68-$16.74 |
Market Cap | $796.9M |
Shares Short | 8M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $18.9M |
Diluted EPS | -$3.32 |
News
See moreYahoo Finance • 7 days ago
CD19 Inhibitors Market to Witness Significant Expansion During the Forecast Period (2025-2034) as Autoimmune and Oncology Pipelines Accelerate | DelveInsight
Yahoo Finance • 27 days ago
TheStreet Pro Analysts Say, “It’s a Stock Picker’s Market – Here Are 4 to Consider”
Yahoo Finance • 3 months ago
Cullinan Therapeutics Showcases Compelling Clinical Data in AML for CLN-049, Novel FLT3xCD3 T Cell Engager, in Oral Presentation at the 67th ASH Meeting
Yahoo Finance • 3 months ago
This Biotech Fund Just Dumped $14.8 Million in MBX Biosciences — Right Before Key 2026 Milestones
About
CEO | Mr. Nadim Ahmed |
Address | One Main Street, Cambridge, MA, United States, 02142 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 109 |
